Treatment of Epidermal Necrolysis with High-Dose Intravenous Immunoglobulins (IVIg): Clinical Experience to Date

Author： Faye Ousmane Roujeau Jean-Claude

ISSN： 0012-6667

Source： Drugs, Vol.65, Iss.15, 2005-01, pp. : 2085-2090

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pyoderma Gangrenosum Treated with High-Dose Intravenous Immunoglobulins: Two Cases and Review of the Literature

By Meyer Nicolas Ferraro Valérie Mignard Marie-Henriette Adamski Henri Chevrant-Breton Jacqueline

Clinical Drug Investigation, Vol. 26, Iss. 9, 2006-01 ,pp. : 541-546

Adis International

Access to resources Recommend Favorite

Update on Intravenous Immunoglobulins (IVIg) Mechanisms of Action and Off- Label use in Autoimmune Diseases

Current Pharmaceutical Design, Vol. 17, Iss. 29, 2011-10 ,pp. : 3166-3175

Bentham Science Publishers

Access to resources Recommend Favorite

Cost Effectiveness of High-Dose Intravenous Esomeprazole for Peptic Ulcer Bleeding

By Barkun Alan N.

PharmacoEconomics, Vol. 28, Iss. 3, 2010-03 ,pp. : 217-230

Adis International

Access to resources Recommend Favorite

Intravenous Immunoglobulins as a Treatment for Alzheimer's Disease: Rationale and Current Evidence

By Dodel Richard

Drugs, Vol. 70, Iss. 5, 2010-03 ,pp. : 513-528

Adis International

Access to resources Recommend Favorite

High-Dose Torasemide is Equivalent to High-Dose Furosemide with Hypertonic Saline in the Treatment of Refractory Congestive Heart Failure

By Salvatore Paterna

Clinical Drug Investigation, Vol. 25, Iss. 3, 2005-01 ,pp. : 165-173

Adis International

Access to resources Recommend Favorite